(VIANEWS) – Legg Mason BW Global Income Opportunities Fund (BWG), Grindrod Shipping Holdings Ltd. (GRIN), TeklaLife Sciences Investors (HQL) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Legg Mason BW Global Income Opportunities Fund (BWG) | 13.54% | 2024-05-09 11:48:06 |
| Grindrod Shipping Holdings Ltd. (GRIN) | 9.81% | 2024-05-04 16:23:06 |
| TeklaLife Sciences Investors (HQL) | 9.6% | 2024-05-11 04:17:05 |
| Baxter International (BAX) | 3.25% | 2024-05-12 03:15:16 |
| Arch Coal (ACI) | 2.33% | 2024-05-08 19:15:05 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Legg Mason BW Global Income Opportunities Fund (BWG) – Dividend Yield: 13.54%
Legg Mason BW Global Income Opportunities Fund’s last close was $8.44, 2.43% under its 52-week high of $8.65. Intraday change was -0.47%.
Legg Mason BW Global Income Opportunities Fund Inc. is a closed ended fixed income mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. The fund is co-managed by Brandywine Global Investment Management, LLC. It invests in fixed income markets. The fund employs fundamental analysis to create its portfolio. Legg Mason BW Global Income Opportunities Fund Inc. was formed on March 28, 2012 and is domiciled in the United States.
Earnings Per Share
As for profitability, Legg Mason BW Global Income Opportunities Fund has a trailing twelve months EPS of $-0.35.
Yearly Top and Bottom Value
Legg Mason BW Global Income Opportunities Fund’s stock is valued at $8.40 at 17:15 EST, below its 52-week high of $8.65 and way higher than its 52-week low of $6.86.
More news about Legg Mason BW Global Income Opportunities Fund.
2. Grindrod Shipping Holdings Ltd. (GRIN) – Dividend Yield: 9.81%
Grindrod Shipping Holdings Ltd.’s last close was $13.96, 6.31% under its 52-week high of $14.90. Intraday change was 1.9%.
Grindrod Shipping Holdings Ltd., an international shipping company, owns, charters-in, and operates a fleet of dry bulk carriers and tankers worldwide. It operates a fleet of 23 owned dry bulk carriers and 8 long-term chartered-in dry bulk carriers that transport a range of bulk and breakbulk commodities, including ores, coal, grains, forestry products, steel products, and fertilizers. The company also operates a fleet of four owned tankers, which carry petroleum products, such as petrol, diesel, jet fuel, and naptha, as well as heavy fuel oil; and low hazard chemical products comprising liquid bulk vegetable oils. Its customers include shipping companies, trading houses, mining companies, industrial manufacturing companies, and oil companies, as well as traders of grains, steel, and forestry products. The company was founded in 1910 and is based in Singapore.
Earnings Per Share
As for profitability, Grindrod Shipping Holdings Ltd. has a trailing twelve months EPS of $-0.49.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.61%.
Sales Growth
Grindrod Shipping Holdings Ltd.’s sales growth for the current quarter is 8.6%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Oct 19, 2023, the estimated forward annual dividend rate is 1.37 and the estimated forward annual dividend yield is 9.81%.
Yearly Top and Bottom Value
Grindrod Shipping Holdings Ltd.’s stock is valued at $13.96 at 17:15 EST, under its 52-week high of $14.90 and way above its 52-week low of $6.80.
Moving Average
Grindrod Shipping Holdings Ltd.’s value is way above its 50-day moving average of $11.30 and way higher than its 200-day moving average of $9.60.
More news about Grindrod Shipping Holdings Ltd..
3. TeklaLife Sciences Investors (HQL) – Dividend Yield: 9.6%
TeklaLife Sciences Investors’s last close was $13.85, 3.62% below its 52-week high of $14.37. Intraday change was 0.22%.
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Earnings Per Share
As for profitability, TeklaLife Sciences Investors has a trailing twelve months EPS of $0.79.
PE Ratio
TeklaLife Sciences Investors has a trailing twelve months price to earnings ratio of 17.53. Meaning, the purchaser of the share is investing $17.53 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.28%.
Yearly Top and Bottom Value
TeklaLife Sciences Investors’s stock is valued at $13.85 at 17:15 EST, below its 52-week high of $14.37 and way higher than its 52-week low of $11.34.
Revenue Growth
Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 3.51M for the twelve trailing months.
More news about TeklaLife Sciences Investors.
4. Baxter International (BAX) – Dividend Yield: 3.25%
Baxter International’s last close was $35.43, 29.44% under its 52-week high of $50.21. Intraday change was -4.25%.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Earnings Per Share
As for profitability, Baxter International has a trailing twelve months EPS of $-0.15.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.42%.
Volatility
Baxter International’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.67%, a negative 0.60%, and a positive 1.12%.
Baxter International’s highest amplitude of average volatility was 0.67% (last week), 1.20% (last month), and 1.12% (last quarter).
Moving Average
Baxter International’s worth is under its 50-day moving average of $40.95 and above its 200-day moving average of $38.98.
Sales Growth
Baxter International’s sales growth for the current quarter is 1.1%.
More news about Baxter International.
5. Arch Coal (ACI) – Dividend Yield: 2.33%
Arch Coal’s last close was $20.74, 13.15% under its 52-week high of $23.88. Intraday change was 0.68%.
Albertsons Companies, Inc., through its subsidiaries, operates as a food and drug retailer in the United States. Its food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. As of February 29, 2020, the company operated 2,252 stores under various banners, including Albertsons, Safeway, Vons, Jewel-Osco, Shaw's, Acme, Tom Thumb, Randalls, United Supermarkets, Market Street, Pavilions, Star Market, Carrs, and Haggen; and 1,726 pharmacies, 1,290 in-store branded coffee shops, and 402 adjacent fuel centers. The company is headquartered in Boise, Idaho. Albertsons Companies, Inc. is a subsidiary of Albertsons Investor Holdings LLC.
Earnings Per Share
As for profitability, Arch Coal has a trailing twelve months EPS of $2.23.
PE Ratio
Arch Coal has a trailing twelve months price to earnings ratio of 9.3. Meaning, the purchaser of the share is investing $9.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 58.86%.
Moving Average
Arch Coal’s worth is higher than its 50-day moving average of $20.68 and under its 200-day moving average of $21.77.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 25, 2024, the estimated forward annual dividend rate is 0.48 and the estimated forward annual dividend yield is 2.33%.
More news about Arch Coal.
